SCHEMBL13601372

SCHEMBL13601372

CC1CCN(CC(=O)OCCN(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRM3 P20309 1/20 0.41
CHRNA4 P43681 1/20 0.41
DNM1 Q05193 1/20 0.41
ALDH1A1 P00352 4/20 0.40
THRB P10828 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
HRH3 Q9Y5N1 2/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601375 0.91 NPC1 (0.39) ALDH1A1SMN1; SMN2NPC1HRH3KMT2A
SCHEMBL13601415 0.85 POLB (0.48) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL12773961 0.84 ALDH1A1 (0.38) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL9243638 0.83 ALDH1A1 (0.48) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL13601367 0.82 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HTTMAPTRAB9A
SCHEMBL13601611 0.81 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL12774078 0.80 BDKRB1 (0.38) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL8259120 0.79 HPGD (0.49) ALDH1A1SMN1; SMN2HRH3MAPTKMT2A
SCHEMBL26290920 0.79 MEN1 (0.51) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL13601630 0.79 NPC1 (0.54) CHRM2CHRM4CHRM5CHRM1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed